0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Transcatheter Aortic Valve Replacement (TAVR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-15W12910
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Transcatheter Aortic Valve Replacement TAVR Sales Market Report 2023
BUY CHAPTERS

Transcatheter Aortic Valve Replacement (TAVR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15W12910
Report
March 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transcatheter Aortic Valve Replacement (TAVR) - Market Size

The global market for Transcatheter Aortic Valve Replacement (TAVR) was estimated to be worth US$ 4008.6 million in 2023 and is forecast to a readjusted size of US$ 12060 million by 2030 with a CAGR of 16.8% during the forecast period 2024-2030

Transcatheter Aortic Valve Replacement (TAVR) - Market

Transcatheter Aortic Valve Replacement (TAVR) - Market

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.
In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcatheter Aortic Valve Replacement (TAVR) by region & country, by Type, and by Application.
The Transcatheter Aortic Valve Replacement (TAVR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Replacement (TAVR).
Market Segmentation

Scope of Transcatheter Aortic Valve Replacement (TAVR) - Market Report

Report Metric Details
Report Name Transcatheter Aortic Valve Replacement (TAVR) - Market
Forecasted market size in 2030 US$ 12060 million
CAGR 16.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Transfemoral Approach
  • Transapical Approach
  • Others
Segment by Application
  • Aortic Stenosis
  • Aortic Regurgitation
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Transcatheter Aortic Valve Replacement (TAVR) - Market size in 2030?

Ans: The Transcatheter Aortic Valve Replacement (TAVR) - Market size in 2030 will be US$ 12060 million.

What is the Transcatheter Aortic Valve Replacement (TAVR) - Market share by type?

Ans: In terms of product, Transfemoral Approach is the largest segment, with a share over 80%.

Who are the main players in the Transcatheter Aortic Valve Replacement (TAVR) - Market report?

Ans: The main players in the Transcatheter Aortic Valve Replacement (TAVR) - Market are Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical

What are the Application segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR) - Market report?

Ans: The Applications covered in the Transcatheter Aortic Valve Replacement (TAVR) - Market report are Aortic Stenosis, Aortic Regurgitation, Others

What are the Type segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR) - Market report?

Ans: The Types covered in the Transcatheter Aortic Valve Replacement (TAVR) - Market report are Transfemoral Approach, Transapical Approach, Others

1 Market Overview
1.1 Transcatheter Aortic Valve Replacement (TAVR) Product Introduction
1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast
1.3 Transcatheter Aortic Valve Replacement (TAVR) Market Trends & Drivers
1.3.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
1.3.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers & Opportunity
1.3.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
1.3.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Ranking (2023)
2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2019-2024)
2.3 Key Companies Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Transcatheter Aortic Valve Replacement (TAVR) Product Offered
2.5 Key Companies Time to Begin Mass Production of Transcatheter Aortic Valve Replacement (TAVR)
2.6 Transcatheter Aortic Valve Replacement (TAVR) Market Competitive Analysis
2.6.1 Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Transfemoral Approach
3.1.2 Transapical Approach
3.1.3 Others
3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type
3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Type (2019-2030)
3.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Aortic Stenosis
4.1.2 Aortic Regurgitation
4.1.3 Others
4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application
4.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Application (2019-2030)
4.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region
5.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2019-2024)
5.1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2025-2030)
5.1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
5.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
5.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
5.4.2 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
5.5.2 South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
5.6.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value
6.3 United States
6.3.1 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.3.2 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.4.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.5.2 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.6.2 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.7.2 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.8.2 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019-2030
6.9.2 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Profile
7.1.2 Edwards Lifesciences Main Business
7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.1.5 Edwards Lifesciences Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.3.5 Boston Scientific Recent Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Profile
7.4.2 Boston Scientific Main Business
7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.4.5 Boston Scientific Recent Developments
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Profile
7.5.2 Meril Life Sciences Main Business
7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.5.5 Meril Life Sciences Recent Developments
7.6 Venus Medtech
7.6.1 Venus Medtech Profile
7.6.2 Venus Medtech Main Business
7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.6.5 Venus Medtech Recent Developments
7.7 Bracco (HLT)
7.7.1 Bracco (HLT) Profile
7.7.2 Bracco (HLT) Main Business
7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.7.5 Bracco (HLT) Recent Developments
7.8 JenaValve Technology
7.8.1 JenaValve Technology Profile
7.8.2 JenaValve Technology Main Business
7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.8.5 JenaValve Technology Recent Developments
7.9 Suzhou Jiecheng Medical Technology Co.
7.9.1 Suzhou Jiecheng Medical Technology Co. Profile
7.9.2 Suzhou Jiecheng Medical Technology Co. Main Business
7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
7.10 Peijia Medical
7.10.1 Peijia Medical Profile
7.10.2 Peijia Medical Main Business
7.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2019-2024)
7.10.5 Peijia Medical Recent Developments
8 Industry Chain Analysis
8.1 Transcatheter Aortic Valve Replacement (TAVR) Industrial Chain
8.2 Transcatheter Aortic Valve Replacement (TAVR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transcatheter Aortic Valve Replacement (TAVR) Sales Model
8.5.2 Sales Channel
8.5.3 Transcatheter Aortic Valve Replacement (TAVR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Transcatheter Aortic Valve Replacement (TAVR) Market Trends
    Table 2. Transcatheter Aortic Valve Replacement (TAVR) Market Drivers & Opportunity
    Table 3. Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
    Table 4. Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
    Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Transcatheter Aortic Valve Replacement (TAVR) Product Type
    Table 9. Key Companies Time to Begin Mass Production of Transcatheter Aortic Valve Replacement (TAVR)
    Table 10. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2019-2024) & (%)
    Table 27. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2025-2030) & (US$ Million)
    Table 31. Edwards Lifesciences Basic Information List
    Table 32. Edwards Lifesciences Description and Business Overview
    Table 33. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Edwards Lifesciences (2019-2024)
    Table 35. Edwards Lifesciences Recent Developments
    Table 36. Medtronic Basic Information List
    Table 37. Medtronic Description and Business Overview
    Table 38. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Medtronic (2019-2024)
    Table 40. Medtronic Recent Developments
    Table 41. Abbott Basic Information List
    Table 42. Abbott Description and Business Overview
    Table 43. Abbott Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Abbott (2019-2024)
    Table 45. Abbott Recent Developments
    Table 46. Boston Scientific Basic Information List
    Table 47. Boston Scientific Description and Business Overview
    Table 48. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Boston Scientific (2019-2024)
    Table 50. Boston Scientific Recent Developments
    Table 51. Meril Life Sciences Basic Information List
    Table 52. Meril Life Sciences Description and Business Overview
    Table 53. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Meril Life Sciences (2019-2024)
    Table 55. Meril Life Sciences Recent Developments
    Table 56. Venus Medtech Basic Information List
    Table 57. Venus Medtech Description and Business Overview
    Table 58. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Venus Medtech (2019-2024)
    Table 60. Venus Medtech Recent Developments
    Table 61. Bracco (HLT) Basic Information List
    Table 62. Bracco (HLT) Description and Business Overview
    Table 63. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Bracco (HLT) (2019-2024)
    Table 65. Bracco (HLT) Recent Developments
    Table 66. JenaValve Technology Basic Information List
    Table 67. JenaValve Technology Description and Business Overview
    Table 68. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of JenaValve Technology (2019-2024)
    Table 70. JenaValve Technology Recent Developments
    Table 71. Suzhou Jiecheng Medical Technology Co. Basic Information List
    Table 72. Suzhou Jiecheng Medical Technology Co. Description and Business Overview
    Table 73. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Suzhou Jiecheng Medical Technology Co. (2019-2024)
    Table 75. Suzhou Jiecheng Medical Technology Co. Recent Developments
    Table 76. Peijia Medical Basic Information List
    Table 77. Peijia Medical Description and Business Overview
    Table 78. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Peijia Medical (2019-2024)
    Table 80. Peijia Medical Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Transcatheter Aortic Valve Replacement (TAVR) Downstream Customers
    Table 84. Transcatheter Aortic Valve Replacement (TAVR) Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Product Picture
    Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Transcatheter Aortic Valve Replacement (TAVR) Report Years Considered
    Figure 5. Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2023
    Figure 7. Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Transfemoral Approach Picture
    Figure 9. Transapical Approach Picture
    Figure 10. Others Picture
    Figure 11. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Aortic Stenosis
    Figure 14. Product Picture of Aortic Regurgitation
    Figure 15. Product Picture of Others
    Figure 16. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value (%), (2019-2030)
    Figure 29. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2023 VS 2030
    Figure 50. Transcatheter Aortic Valve Replacement (TAVR) Industrial Chain
    Figure 51. Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Medical Nasal Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2P14533
Thu May 02 00:00:00 UTC 2024

Add to Cart

Synthetic Fiber Vascular Prosthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38F13932
Thu May 02 00:00:00 UTC 2024

Add to Cart

Rapamycin Target Eluting Stent System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-33P14399
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Add to Cart